` 185750 (Chong Kun Dang Pharmaceutical Corp) vs KOSPI 200 Comparison - Alpha Spread

185750
vs
KOSPI 200

Over the past 12 months, has underperformed KOSPI 200, delivering a return of -22% compared to the KOSPI 200's 8% drop.

Stocks Performance
185750 vs KOSPI 200

Loading

Performance Gap
185750 vs KOSPI 200

Loading
185750
KOSPI 200
Difference

Performance By Year
185750 vs KOSPI 200

Loading
185750
KOSPI 200
Add Stock

Competitors Performance
Chong Kun Dang Pharmaceutical Corp vs Peers

KOSPI 200
185750
LLY
JNJ
NOVO B
ROG
Add Stock

Chong Kun Dang Pharmaceutical Corp
Glance View

Market Cap
1T KRW
Industry
Pharmaceuticals

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Intrinsic Value
80 430.71 KRW
Undervaluation 2%
Intrinsic Value
Price
Back to Top